184 related articles for article (PubMed ID: 7522951)
41. Clinical characteristics and outcomes of extrauterine epithelioid trophoblastic tumors.
Zhang T; Zeng X; Xu H; Gao L; Xiong L; An R; Xue Y
Arch Gynecol Obstet; 2019 Sep; 300(3):725-735. PubMed ID: 31312959
[TBL] [Abstract][Full Text] [Related]
42. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
Kunhardt J; Calderón J; Rodríguez S; Fletcher P; Ayala A; Reyes V
Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
[No Abstract] [Full Text] [Related]
43. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
Quigley MM; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
[TBL] [Abstract][Full Text] [Related]
44. Elevated hCG and a high proportion of hCGbeta in serum preceding the diagnosis of trophoblastic disease by seven months.
Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
BJOG; 2002 May; 109(5):589-90. PubMed ID: 12066956
[No Abstract] [Full Text] [Related]
45. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
46. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
Jones WB; Lehr M; Lewis JL
Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
[No Abstract] [Full Text] [Related]
47. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
48. [Clinical usefulness of color doppler flow examination during treatment of gestational trophoblastic disease].
Bidziński M; Sobiczewski P; Derlatka P; Pietrzak K; Wierzba W
Ginekol Pol; 1999 Feb; 70(2):88-92. PubMed ID: 10349813
[TBL] [Abstract][Full Text] [Related]
49. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
[TBL] [Abstract][Full Text] [Related]
50. Invasive mole of the uterus- a rare case diagnosed by ultrasound: a case report.
Nair K; Al-Khawari H
Med Ultrason; 2014 Jun; 16(2):175-8. PubMed ID: 24791851
[TBL] [Abstract][Full Text] [Related]
51. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
53. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
[TBL] [Abstract][Full Text] [Related]
54. The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
Bidziñski M; Lemieszczuk B; Drabik M
Eur J Gynaecol Oncol; 1997; 18(6):541-3. PubMed ID: 9443032
[TBL] [Abstract][Full Text] [Related]
55. Color Doppler flow as an indicator of trophoblastic activity in tubal pregnancies detected by transvaginal ultrasound.
Tekay A; Jouppila P
Obstet Gynecol; 1992 Dec; 80(6):995-9. PubMed ID: 1448271
[TBL] [Abstract][Full Text] [Related]
56. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
57. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
58. [Gestational trophoblastic tumors--a report of experiences].
Ebeling K; Schönborn I; Johannsmeyer D
Zentralbl Gynakol; 1995; 117(5):237-42. PubMed ID: 7540787
[TBL] [Abstract][Full Text] [Related]
59. Localization of trophoblastic disease with vaginal ultrasonography. A report of two cases.
Ansbacher R; Hopkins MP; Roberts JA; Randolph JF
J Reprod Med; 1990 Aug; 35(8):835-8. PubMed ID: 2170643
[TBL] [Abstract][Full Text] [Related]
60. Sonographic patterns of pelvic and hepatic lesions in persistent trophoblastic disease.
Woo JS; Wong LC; Ma HK
J Ultrasound Med; 1985 Apr; 4(4):189-98. PubMed ID: 2580992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
